Dear Colleagues,

We are honoured to announce the 24^th edition of The World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI) to be held November 10-13, 2016 in the beautiful city of Amsterdam, Netherlands.

The 24th COGI Congress has been designed to provide an innovative and comprehensive overview of the latest research developments in the field, primarily in the areas of IVF, family planning, menopause and perinatology.

Many distinguished gynecologists and scientists have joined the faculty and will take part in this Congress. All of them will present their experience and research in the form of debates, discussion, plenary lectures and symposia.

We also invite young scientists to join us in Amsterdam and submit their abstracts for either oral presentation or ePoster as well as joining the “Young Scientist Award” competition.

We will of course continue with the “Annual Robert G. Edwards, Nobel Prize Laureate Lecture” which will host a special speaker whom you will hear from for the first time at COGI.

We hope that you will find the 24^th COGI Congress as interesting as ever, and we are looking forward to meeting you in Amsterdam

Sincerely,

Zion Ben Rafael

On behalf of the Organizing Committee

INFERTILITY

• Principles of ovarian stimulation
• Gonadotropin Isoforms
• Ovarian stimulation- the role of hCG
• Where AMH fits into controlled ovarian stimulation
• PCOS
• Low ovarian reserve
• Infertility in older age
• Quality of Laboratory work
• Lab-technologies needed to maximize success
• PGS- central or marginal role in improving the results of ART?
• Time Lapse: Does it add to laboratory work?
• Fertility preservation: Ovarian and oocyte cryopreservation
• Recent advances and new frontier in cryopreservation
• Vitrification
• Implantation failure
• Genetic endometrial receptivity map
• Recurrent miscarriages: New pathological pathways
• Dealing with ART failure: What to offer next?
• Metabolic dysfunction and its implications
• WHO: Infertility guidelines
• Treating fibroids in infertile women
• Mechanical infertility
• How to treat Adenomyosis in infertile women?
• Does endometriosis affect ART results?
• RTD: Burning clinical issues
• Nnutritional supplements for fertility: Evidence based?
• Mitochondrial diseases and mitochondrial addition
• Update on male infertility
• Can ovarian response to stimulation predict early menopause
• Highly cited Dutch research in Reproductive Medicine

GYNECOLOGY, HPV, MENOPAUSE, ENDOMETRIOSIS, FAMILY PLANNING

• Epidemiology of HPV and cancer
• HPV tests for screening
• The value and opportunities of HPV vaccines
• Healthy female aging
• Life style and menopause
• HRT and Osteoporosis Prevention
• Management and Menopause
• Non hormonal management of menopause
• Calcium and Vitamin-D: Protection or Harm?
• Vulvovaginal atrophy: What can be achieved by laser?
• HRT and Osteoporosis Prevention: Are we under-using the best treatment option?
• Is the risk of thromboembolism different with different pills?
• Mechanism of OC’s related thrombosis.
• Management of endometriosis
• Fertility preservation in women with endometriosis
• Ovarian reserve following endometrioma excision
• Medical or Surgical treatment for fibroids

FETO-MATERNAL MEDICINE (FMM)

• The great Obstetrical Syndromes: Common pathways and possibilities of prevention
• Gestational Diabetes
• Prevention of Pregnancy Complications Preeclampsia
• Angiogenic factors in the diagnosis and short term prediction of preeclampsia
• The debate goes on: Progesterone, Cerclage, Arabin Pessary?
• Preterm Birth: Still an enigma but progesterone can help to prevent
• Avoiding Recurrent Miscarriage: Do we have a clue?
• Prenatal diagnosis in the ERA of NIPT
• Intrapartum fetal monitoring Benefit or Risk?
• Perspective on preconception care and future health of off-spring
• Vitamins what is new?
• Omega 3 during pregnancy: Worth taking?
• What is the optimal weight gain?
• Exercise: What is OK and what is not
• Fetal risks to obese patient. How to deliver the morbidly obese patient?
• Can we prevent neurological disorders in the mother and the newborn?
• Second stage of labor: How long is too long
• Can better understanding decrease litigation?
• Intrapartum fetal monitoring
• Vacuum Vs. forceps
• Does a Caesarean section increase the time to a second live birth?
• CS Vs. instrumental delivery at the second stage
• Cesarean section: Classification and its meaning

Isaac Blickstein, Israel
Kaplan Medical Centre

Xavier Bosch, Spain
Health University Barcelona Camus

Frank Broekmans, Netherlands
University Medical Center Utrecht

Jacques Donnez, Belgium
Catholic University of Louvain

Bart C.J.M. Fauser, Netherlands
University of Utrecht

Simon Fishel, UK
CARE Fertility Group

Arie Franx, Netherlands
University Medical Center Utrecht

Yacoub Khalaf, UK
Guy’s Hospital

Nils Lambalk, Netherlands
VU University medical centre in Amsterdam

Robert Langer, USA
University of Nevada

Kirsten Macklon, Denmark
Fertility Clinic, Rigshospitalet

Jane Norman, UK
Tommy’s Centre for Maternal and Fetal Health

Felice Petraglia, Italy
University of Siena

Gian Carlo di Renzo, Italy
University of Perugia

Eric Steegers, Netherlands
Erasmus MC

Andrea Tinelli, Italy
“Vito Fazzi” Hospital

Rita Vassena, Spain
Clinica Eugin

Yariv Yogev, Israel
Lis Hospital of Women

Register for the COGI experience

EUR

More Info: Group registrations for 10 or more

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Important Information

• Each submitter can present up to 2 abstracts (only 1 of which can be an oral presentation).
• Creation of a user account is required for the submission of an abstract.
• Accepted abstract presenters must register and pay their registration fees by the deadline date noted in the letter of acceptance.  If payment is not received by the deadline date (or is received after the deadline date), the abstract(s) will be automatically withdrawn and will not appear in the Program or Abstract Book.
• The Scientific Committee may request pre-registration from abstract submitters prior to abstract review.

After submission

• Submitting authors will be notified as to whether their abstract has been accepted, as well as the date, time and form of their presentation.
• Any change of the presenting author needs to be communicated in the form of a written statement to the Scientific Committee.
• If the original presenting author is unable to present the abstract, it is that person’s responsibility to ensure that one of the co-authors takes over this role.
• It is the duty of the original presenting author to advise the Congress Secretariat (cogi@congressmed.com) in writing of his successor’s full name and email address.
• If you decide to withdraw your abstract, a written request must be submitted to the COGI Secretariat (cogi@congressmed.com) no later than 31 August, 2016.

Abstract submission deadline 2016-08-31

Oral presentation: The abstract is selected for oral presentation at any of the Free Communication sessions. –> Note: The number of oral presentations is limited. Abstracts with preference for oral presentation will be selected by the Scientific committee.Abstracts should be submitted in English and contain no more than 3,600 characters, including titles, graphs and non-visible characters, such as spaces and line breaks.
Please write concisely and clearly and follow this structure:

  Problem statement: Why do we care about the problem?

  Methods: What did you actually do to get your results?

  Results: What did you learn/invent/create?

  Conclusion: What are the implications of your findings?

Please ensure that your abstract does not contain spelling, grammar or scientific mistakes, as it will be reproduced exactly as submitted. No proof reading will be done. Linguistic accuracy is the responsibility of the submitter.

Best Abstracts awards will be considered in the following disciplines

Under 34 competition

Best Breakthrough & Innovation Abstract

The winners will be announced and presented at the opening ceremony.

Under 34 Competition

Who is eligible to enter?

Young Physicians, Scientists & Researchers age 34 and under

What is this competition all about?

The Scientific Committee of the COGI Amsterdam Congress invites scientists under the age of 34 to submit their work and to join the Young Scientist Awards.

The Best 2 Abstracts will receive free registration and their abstracts will be presented as oral presentations.

The next 5 Best Abstracts will receive a 100 Euro discount on registration.

Wow! How do I enter?

It’s very simple. Submit your abstract via the Congress website. If your abstract is selected as one of the Best Abstract winners and you have already paid the full registration fee, we will refund you.

Great! So what are the guidelines for submitting?

Submitters must be under the age of 34 at the time of submission. Please remember to fill in date of birth in the appropriate place on the online registration form

Submitters must be the first author of the abstract

Submitters must register and pay registration fees by September 30, 2016

Attendance at the Congress by the winner is mandatory in order to receive and collect the award

Winners who cancel for any reason (whether or not registration fees have been paid), will not be entitled to collect their award

Only the winner can claim their award on site at the Congress

Submit the abstract on-line: www.congressmed.com/cogilisbon

Best Breakthrough & Innovation Abstract

The best 4 Abstracts will be selected by the Chairment of COGI. The winners will receive free registration and will present their presentation during the Breakthrough & Innovation Session.

Who is eligible to enter?

Every abstract submitter automatically takes part in the competition

What is this competition all about?

The Breakthrough & Innovation Session is a new approach at COGI with the aim to enhance science and research in the field of Women’s Healthcare.

Note that abstracts sent by email or fax will automatically be rejected.

Don’t wait until the deadline. 

Early submission increases your chance to win.

CongressMed
Tel. +972 73 706 6950
Fax. +972 3 725 6266
E-mail: industry@congressmed.com